Document Detail


New trends in hyperosmolar therapy?
MedLine Citation:
PMID:  23385373     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: To discuss trends in the use of osmotic therapy.
RECENT FINDINGS: Use of osmotic therapy has evolved from bolus administration of mannitol to routine use of hypertonic saline as a bolus as well as in continuous infusions to creating a sustained hyperosmolar state.In a survey of neurointensivists 55% favored hypertonic saline over mannitol. Retrospective studies suggest better intracranial pressure (ICP) control with hypertonic saline. Whereas a prospective study in adults with head injury compared alternating doses of mannitol and hypertonic saline and found no difference in change in ICP control or outcome, two meta-analyses, which did not include this study, favored hypertonic saline for ICP control (although the absolute difference of 2 mmHg is of little clinical value) with no difference in outcome.Hypertonic saline has also been administered by infusions to creating a sustained stable hyperosmolar state. Two studies, using historical controls, suggested benefit of hypertonic saline infusions. In a prospective, randomized study, in children with severe head injury Lactated Ringer's solution was compared to hypertonic saline. Although ICP control was similar, the hypertonic saline group required fewer other interventions.
SUMMARY: The existing data do not support favoring boluses of hypertonic saline over mannitol in terms of ICP control, let alone outcome. The rationale for continuous infusions to create a sustained hyperosmolar state is open to discussion and use of this approach should be curtailed pending further research.
Authors:
Michael N Diringer
Related Documents :
23216593 - Assessing efficacy in myelofibrosis treatment: a focus on jak inhibition.
23058983 - How can we use depression severity to guide treatment selection when measures of depres...
23597323 - Moderators of the treatment response to guided self-instruction for chronic fatigue syn...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current opinion in critical care     Volume:  19     ISSN:  1531-7072     ISO Abbreviation:  Curr Opin Crit Care     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-05     Completed Date:  2013-10-21     Revised Date:  2014-04-02    
Medline Journal Info:
Nlm Unique ID:  9504454     Medline TA:  Curr Opin Crit Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  77-82     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain Ischemia / drug therapy*,  physiopathology
Cerebral Hemorrhage / drug therapy*,  physiopathology
Craniocerebral Trauma / drug therapy*,  physiopathology
Critical Care / methods,  trends*
Diuretics, Osmotic / pharmacology,  therapeutic use*
Female
Humans
Intracranial Hypertension / drug therapy*,  physiopathology
Male
Mannitol / pharmacology,  therapeutic use*
Osmolar Concentration
Practice Guidelines as Topic
Saline Solution, Hypertonic / pharmacology,  therapeutic use*
Treatment Outcome
Grant Support
ID/Acronym/Agency:
5P50NS05597704/NS/NINDS NIH HHS; P50 NS035966/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Diuretics, Osmotic; 0/Saline Solution, Hypertonic; 3OWL53L36A/Mannitol
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Extracorporeal liver support.
Next Document:  Haemoglobin management in acute brain injury.